Skip to content

For Private Equity, Private Credit & Real Assets Managers

This page is written for: Private equity managers, private credit funds, venture capital firms and real assets managers who are exploring how listed structured products can provide access to a broader investor base, create co-investment vehicles, or establish a listed distribution channel alongside an existing fund structure. Orpheus Capital provides structuring and operational enablement support — we do not provide investment advice to end investors and we do not assess investor suitability.

Package Private Market Strategies into
Listed, Transferable Structures

Private capital managers have long had access to deep pools of institutional capital. Listed structured products open a parallel pathway — to professional investors, family offices and high-net-worth individuals who access capital markets through brokers and platforms. Getting there requires more than a strong track record.

The Structural Challenge

Private Markets Strategies Face Real Distribution Barriers

Raising capital through bilateral negotiations with institutional investors is viable at scale, but it closes off large pools of professionally managed capital that sit in brokerage accounts, wrap platforms and discretionary mandates. A listed structured product can reach those investors — but only if the structure is designed to meet their operational and regulatory requirements from the outset.

Private fund vehicles — limited partnerships, offshore funds, side-pocket arrangements — are well-suited to institutional capital but present practical obstacles for distributors serving professional retail and high-net-worth clients. They lack ISINs that platforms can recognise. They require bilateral subscription agreements. They impose operational burdens on advisers whose clients hold custody accounts through mainstream brokers. They may also sit outside the investor classification frameworks that apply to those clients.

A listed structured product carrying the underlying strategy's economics can resolve most of these barriers. It trades on a recognised exchange. It carries an ISIN. It can be held in standard custody accounts and transferred on secondary markets. It can be structured with a redemption architecture that reflects the illiquidity of the underlying assets — without requiring the manager to offer daily liquidity they cannot operationally support.

The structure does not change the strategy. It changes who can access it and through which channels — and that determination has to be made before the product is designed, not after it is launched.

Orpheus Capital works with private capital managers at the intersection of strategy and structure — evaluating the design choices that determine whether a product can be held, distributed and administered by the counterparties the manager needs to reach.

Common Objectives

What Private Capital Managers Are Trying to Achieve

The starting point is rarely the vehicle. It is a specific capital-raising, distribution or operational objective that a listed structure might help realise.

Creating a listed access vehicle that allows professional investors and high-net-worth clients to gain exposure to a private equity or credit strategy through their existing broker or platform

Establishing a co-investment vehicle in listed form, providing transferable, ISIN-bearing instruments to co-investors without requiring bilateral side-letter arrangements for each participant

Offering exposure to a flagship fund's returns through a feeder structure that sits alongside the main fund without requiring restructuring of existing investor arrangements

Accessing wealth management distribution channels — discretionary fund managers, private banks, multi-family offices — that require listed, platform-compatible instruments

Structuring a single-deal or deal-by-deal vehicle for a specific transaction, providing a clean, documented structure for a defined set of professional investors

Creating a listed product for a real assets or infrastructure strategy that provides investors with secondary-market liquidity and standard custodial access without compromising the manager's long-term hold horizon

Design Decisions That Cannot Be Deferred

What Has to Be Resolved Before Issuance

Listed structured products for private capital strategies carry a set of design decisions that interact with one another. Deferring any of them adds cost and risk — and some cannot be changed once the product is live.

01

Mandate Scope

The investment mandate must be defined with sufficient precision to support the product's disclosure documents. Broad or aspirational mandates create disclosure problems and operational ambiguity around valuation and performance attribution.

02

Investor Classification

The intended investor base determines permissible documentation standards, distribution channels and jurisdictional requirements. Misalignment between the investor type and the chosen structure is one of the most common and costly errors in private capital listings.

03

Liquidity Architecture

Redemption windows, lock-up periods, gate provisions and secondary market mechanics must reflect the actual liquidity profile of the underlying assets — and must be disclosed clearly. Attempting to offer more liquidity than the strategy can support creates operational and reputational risk.

04

Valuation Methodology

How the NAV is calculated, who calculates it, and how frequently it is published must be specified in the product documentation and agreed with the administrator and the exchange. Retrospective changes are costly and can trigger disclosure obligations.

05

Reporting Standards

Periodic reporting requirements — frequency, format, look-through depth, currency and distribution channel requirements — must be agreed with service providers at the design stage. The reporting infrastructure cannot be easily modified after launch.

06

Fee and Governance Structure

Management fees, performance fees, hurdle rates and governance arrangements must be clearly documented. Where the listed vehicle invests into an existing fund, conflicts of interest, fee layering and the relationship between vehicle governance and fund governance all require explicit treatment.

What Orpheus Provides

Structuring Support from Mandate to Listing

Orpheus works alongside the manager's legal, compliance and investment teams to navigate the design decisions that determine whether a product can be brought to market and distributed through the target channels.

  • Initial feasibility assessment of whether the proposed strategy and investor target market are compatible with a listed structure, and which structural formats are most appropriate
  • Mandate design and documentation — working with the manager's legal counsel to define the investment mandate, fee structure and governance arrangements at the precision required for listed product disclosure
  • Liquidity architecture — designing redemption windows, lock-up provisions and secondary market arrangements that reflect the strategy's actual liquidity profile and the requirements of the target distribution channel
  • Valuation framework — specifying valuation methodology, frequency and governance, and coordinating with the appointed administrator to ensure the framework is operationally viable
  • Exchange and regulatory liaison — coordinating with the listing exchange, legal counsel and regulatory advisers to manage the listing process and ensure filing requirements are met
  • Service provider identification and onboarding — helping to identify and coordinate between the administrator, custodian, auditor, legal counsel and listing agent required to support the product
  • Distribution channel alignment — advising on the product characteristics and documentation features that are likely to support acceptance by target wealth management distributors, platforms and brokers
  • Reporting specification — defining periodic reporting outputs, format and distribution requirements with service providers before issuance to avoid costly post-launch changes

Common Questions

Questions from Private Capital Managers

Can a private fund strategy be packaged as a listed structured product?

Yes, in many cases. The viability depends on the nature of the underlying strategy, the target investor base and the jurisdiction in which the product will be listed and distributed. Illiquid or long-dated strategies require specific structural considerations around valuation, redemption mechanics and disclosure. Orpheus works with managers to assess which structural format is most appropriate given the strategy's characteristics and the distribution objectives — before committing to a specific approach.

How are illiquid underlying assets valued inside a listed structure?

Valuation methodology for illiquid assets must be defined in the product's documentation and agreed with the appointed valuation agent and administrator. Common approaches include periodic independent valuation, manager-provided valuations subject to independent oversight, and reference to most recent transaction prices. The chosen methodology must be consistent with the product's disclosure requirements and the expectations of the relevant stock exchange. These parameters need to be established at the structuring stage, as retrospective changes to valuation methodology are operationally complex and can affect investor confidence.

Can a listed product have periodic redemption windows rather than daily liquidity?

Yes. Listed structured products can be designed with redemption mechanics that match the liquidity profile of the underlying strategy — including quarterly, semi-annual or annual redemption windows, lock-up periods and gate provisions. The secondary market listing provides an additional liquidity pathway between redemption windows without requiring the manager to liquidate underlying positions. The specific redemption architecture must be specified in the product's documentation and disclosed clearly to investors at the time of subscription.

What investor classifications are typical for private capital structures?

Private capital strategies are typically distributed to professional or sophisticated investors as defined under the applicable regulatory framework — this may include institutional investors, high-net-worth individuals meeting prescribed criteria, and qualified investors in certain jurisdictions. The investor classification determines the disclosure standards, the product documentation requirements and the distribution channels through which the product can be offered. These parameters are set at the structuring stage and cannot easily be altered post-issuance. Orpheus helps managers identify the investor classifications that align with their target market and the structural requirements that follow.

Can the listed vehicle be used alongside or as a feeder into an existing fund?

Yes. A listed structured product can be designed to invest into an existing fund or separately managed account, creating a listed access vehicle without requiring the manager to restructure the flagship strategy. This approach allows the manager to maintain the fund's operational infrastructure while offering a separately distributed, ISIN-bearing product to investors who access capital markets through brokers and platforms. The structural relationship between the listed vehicle and the underlying fund — including fees, reporting and any conflicts of interest — must be fully disclosed in the product documentation.

Can co-investment opportunities be structured as listed products?

Yes. Co-investment alongside a flagship fund or into a specific transaction can be structured as a listed vehicle, providing a transferable, ISIN-bearing instrument that investors can hold through their standard broker or custody arrangement. This avoids the operational complexity of managing a large number of direct co-investors through bilateral side letters. The scope of the co-investment mandate, governance, reporting and exit mechanics all need to be defined clearly at the structuring stage. Orpheus has experience structuring single-deal and multi-deal co-investment vehicles across asset classes.

Can Orpheus manage the listing and post-issuance compliance requirements?

Orpheus provides support through the listing process including exchange liaison, documentation review and regulatory filing coordination. Ongoing post-issuance requirements — including periodic reporting obligations, NAV publication, corporate actions and regulatory announcements — are typically managed by the appointed administrator and listing agent, who are identified as part of the structuring process. Orpheus can help specify these operational requirements and identify appropriate service providers, but the ongoing compliance obligations are the responsibility of the product's designated parties as set out in the product documentation.

Next Steps

Structuring Assessment

Explore Whether Your Strategy Is Suitable for a Listed Structure

A preliminary conversation with Orpheus can establish whether your strategy is a realistic candidate for a listed vehicle, which structural formats are most appropriate, and what the key design decisions are before work begins.

Request a Structuring Assessment

Capital Access Discussion

Talk Through Your Capital Raising Objectives

If you are at an earlier stage and want to understand the landscape of options — what a listed vehicle can and cannot offer a private capital manager, and what the process typically looks like — a direct conversation is the right starting point.

Request a Capital Access Discussion

This page is intended for professional and institutional readers who are considering the use of listed structured products in a capital-raising or distribution context. It does not constitute investment advice, financial product advice, legal advice or a solicitation to invest. Orpheus Capital provides structuring and operational enablement services and does not provide investment advice to end investors. All structural options are subject to applicable regulatory, legal and exchange requirements in the relevant jurisdiction. Nothing on this page should be interpreted as a guarantee of outcome, regulatory approval or investor acceptance.

Orpheus Capital. For professional and institutional enquiries only.